4//SEC Filing
GLENN JOHN 4
Accession 0001253497-25-000010
CIK 0001325618other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:00 PM ET
Size
14.9 KB
Accession
0001253497-25-000010
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
GLENN JOHN
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-12-07+10,504→ 13,004 total - Tax Payment
Common Stock
2025-12-07$94.57/sh−3,383$319,930→ 9,621 total - Exercise/Conversion
Common Stock
2025-12-07+21,008→ 30,629 total - Tax Payment
Common Stock
2025-12-07$94.57/sh−8,267$781,810→ 22,362 total - Exercise/Conversion
Restricted Stock Units
2025-12-07−10,504→ 0 total→ Common Stock (10,504 underlying) - Exercise/Conversion
Performance-based Restricted Stock Units
2025-12-07−21,008→ 0 total→ Common Stock (21,008 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares.
- [F3]The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in full on the third anniversary of the grant date, December 7, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
- [F4]On December 7, 2022, the reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2022 through December 7, 2025.
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0001253497
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:00 PM ET
- Size
- 14.9 KB